LncRNAs | Relationship | mRNAs | Function prediction of DE lncRNAs with related mRNAs | |||||
---|---|---|---|---|---|---|---|---|
Sequence name | Fold change | Regulation | GeneSymbol | Fold change | Regulation | Molecular Function | Pathway | |
ENSMUST00000160110 | 3.9130898 | Down | Antisense overlap | Phtf1 | 2.1720073 | Down | GO:0003677 DNA binding | Â |
AK136749 | 2.089502 | Up | Antisense overlap | Asap2 | 8.8652115 | Up | Â | Â |
ENSMUST00000121460 | 11.624642 | Up | Antisense overlap | Mup2 | 16.324926 | Up | GO:0005215 transporter activity GO:0005550 pheromone binding | Â |
mouselincRNA1303+ | 2.959626 | Up | Intergenic | Vmn1r54 | 2.5373068 | Up | Â | Â |
MM9LINCRNAEXON12110+ | 9.611986 | Up | Intergenic | Apoa2 | 5.3063893 | Up | GO:0005319 lipid transporter activity GO:0008035 high-density lipoprotein binding GO:0017127 cholesterol transporter activity GO:0042803 protein homodimerization activity GO:0046982 protein heterodimerization activity GO:0055102 lipase inhibitor activity GO:0060228 phosphatidylcholine-sterol O-acyltransferase activator activity | PPAR signaling pathway |
MM9LINCRNAEXON11813− | 2.2022471 | Up | Intergenic | Ngfr | 2.3073637 | Up | GO:0005030 neurotrophin receptor activity GO:0048406 nerve growth factor binding | Neurodegenerative disorders Cytokine–cytokine receptor interaction |
C75950 | 2.3177905 | Up | Intergenic | Gm5136 | 2.2296717 | Down | Â | Â |
mouselincRNA1231− | 2.3548565 | Up | Intergenic | Hvcn1 | 2.0545347 | Up | GO:0005244 voltage-gated ion channel activity GO:0030171 voltage-gated proton channel activity |  |
ENSMUST00000133243 | 2.2177694 | Up | Intergenic | Uspl1 | 2.747246 | Up | GO:0004221 ubiquitin thiolesterase activity | Â |
MM9LINCRNAEXON11661+ | 20.514269 | Up | Intergenic | Asap2 | 8.8652115 | Up | Â | Â |
humanlincRNA1070+ | 6.5686955 | Up | Intergenic | Vax2 | 17.30259 | Up | GO:0003700 transcription factor activity | Â |
humanlincRNA2255− | 6.4199057 | Up | Intergenic | Trhr | 2.1457152 | Down |  |  |
mouselincRNA1631+ | 2.131738 | Up | Intergenic | Klhl15 | 2.0060081 | Up | GO:0005515 protein binding | Â |
humanlincRNA1443− | 4.366208 | Up | Intergenic | Igsf10 | 7.495438 | Up | GO:0005021 vascular endothelial growth factor receptor activity GO:0005515 protein binding GO:0005524 ATP binding |  |
MM9LINCRNAEXON12110+ | 9.611986 | Up | Intergenic | Dedd | 2.2202826 | Down | GO:0003677 DNA binding GO:0005515 protein binding | Â |
MM9LINCRNAEXON10576− | 5.209898 | Up | Intergenic | Cxcl9 | 5.6018896 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
MM9LINCRNAEXON11308+ | 3.7596319 | Up | Intergenic | Zfp654 | 2.1100945 | Down | GO:0003677 DNA binding GO:0008270 zinc ion binding | Â |
BM248967 | 6.0079184 | Up | Intergenic | Dgkk | 3.3316648 | Up | GO:0004143 diacylglycerol kinase activity | Â |
MM9LINCRNAEXON11616+ | 2.5639145 | Up | Intergenic | Hexb | 2.0003252 | Up | GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds GO:0004563 beta-N-acetylhexosaminidase activity GO:0042803 protein homodimerization activity GO:0043169 cation binding GO:0046982 protein heterodimerization activity | N-Glycan degradation Aminosugars metabolism Glycosaminoglycan degradation Glycosphingolipid biosynthesis—globoseries Glycosphingolipid biosynthesis—ganglioseries Glycan structures—degradation |
uc008iab.1 | 2.1543121 | Down | Intergenic | Fam160b1 | 2.5731633 | Up | Â | Â |
MM9LINCRNAEXON12066− | 4.066157 | Down | Intergenic | Tnnt2 | 3.0204759 | Down | GO:0005200 structural constituent of cytoskeleton |  |
MM9LINCRNAEXON10576− | 5.209898 | Up | Intergenic | Cxcl11 | 2.7319772 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
MM9LINCRNAEXON10576− | 5.209898 | Up | Intergenic | Cxcl10 | 6.9877048 | Up | GO:0008009 chemokine activity | Cytokine–cytokine receptor interaction Toll-like receptor signaling pathway |
AK054438 | 2.3012707 | Up | Intergenic | Ifi202b | 9.431554 | Up | GO:0005515 protein binding | Â |
MM9LINCRNAEXON10268− | 6.8239675 | Up | Intergenic | Irf8 | 2.335659 | Up | GO:0003700 transcription factor activity |  |
MM9LINCRNAEXON11735+ | 2.4868224 | Down | Intergenic | Ppp2r5c | 2.1656942 | Down | GO:0008601 protein phosphatase type 2A regulator activity | Â |
DV650983 | 2.0293975 | Down | Intergenic | Olfr1416 | 2.2257524 | Up | GO:0004984 olfactory receptor activity | Olfactory transduction |
MM9LINCRNAEXON11795+ | 2.5727692 | Down | Intergenic | Cd68 | 2.6843183 | Up | Â | Â |
MM9LINCRNAEXON11793+ | 2.671865 | Up | Intergenic | Cd68 | 2.6843183 | Up | Â | Â |
ENSMUST00000120184 | 2.5531633 | Down | Sense overlap | Amy2b | 2.4439986 | Down | Â | Â |
uc007vpp.1 | 2.1796808 | Down | Sense overlap | Trhr | 2.1457152 | Down | GO:0004872 receptor activity GO:0004997 thyrotropin-releasing hormone receptor activity | Calcium signaling pathway Neuroactive ligand–receptor interaction |
uc009pmr.1 | 3.20246 | Down | Sense overlap | Elmod1 | 2.2530112 | Down | Â | Â |
uc007cua.1 | 6.378551 | Down | Sense overlap | Tnnt2 | 3.0204759 | Down | Â | Â |
ENSMUST00000040306 | 4.188862 | Down | Sense overlap | H2-Ea-ps | 3.2939498 | Down | Â | Â |
uc008uzw.1 | 2.2820547 | Up | Sense overlap | Laptm5 | 2.1142242 | Up | Â | Â |
ENSMUST00000117412 | 2.5116289 | Up | Sense overlap | Gm10147 | 2.2881203 | Up | Â | Â |
ENSMUST00000119882 | 3.1487308 | Up | Sense overlap | Gm10486 | 2.4736855 | Up | Â | Â |
ENSMUST00000119882 | 3.1487308 | Up | Sense overlap | Gm14819 | 3.018787 | Up | Â | Â |
uc008tbm.1 | 10.098583 | Up | Sense overlap | Mup17 | 21.82689 | Up | Â | Â |